ClinicalTrials.govcontrolled
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT05384587. IPD Sharing: YES. Countries: 1. Publications: 1.
ShareScore
36/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8